Switch View
© PR Newswire
30.09.2025
ISIN: NL0011606264
Merus N.V.
MRUS
LISTED
NASDAQ
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 1st Merus N.V. (NASDAQ: MRUS)
News Preview
NEW YORK, Sept. 30, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquar...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Tilray, leader mondial du cannabis médical, annonce l’expansion de sa gamme de cannabis Craft haut de gamme dans son centre de production en Allemagne, conforme aux normes BPF de l’UE. Tilray Medical enrichit le portefeuille de produits à base de cannabis
News Preview
NEUMÜNSTER, Allemagne, 01 oct. 2025 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. (NASDAQ : TLRY et TSX : TLRY) et un leader mondial du cannabis thérapeutique qui permet aux patients et aux professionnels de santé de prendre ensemble des décisions de santé individualisées éclairées, transformant ainsi le secteur de...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US66987V1098
Novartis AG (ADR)
NVS
LISTED
NYSE
Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)
News Preview
Rhapsido helps to inhibit release of histamine and proinflammatory mediators by targeting BTK, offering unique approach to CSU treatment
1
Well-controlled dis...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© PR Newswire
30.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Sept. 30, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lantheus Holdings, Inc. ("Lantheus" or "the Company") (NASDAQ: LNTH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Ru...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
30.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK Investors Have Opportunity to Join Cytokinetics, Incorporated Fraud Investigation with the Schall Law Firm
News Preview
LOS ANGELES, Sept. 30, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cytokinetics, Incorporated ("Cytokinetics" or "the Company") (NASDAQ: CYTK) for violations of the securities laws....
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CYTK
News Preview
LOS ANGELES, Sept. 30, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Cytokinetics, Incorporated ("Cytokinetics" or "the Company") (NASDAQ: CYTK ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Sept. 30, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Altimmune, Inc. ("Altimmune" or "the Company") (NASDAQ: ALT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US40412C1018
HCA Healthcare Inc
HCA
LISTED
NYSE
HCA Healthcare Presents 2025 Awards of Distinction
News Preview
HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today presented its annual HCA Healthcare Awards of Distinction at a ceremony in Nashville, Tennessee. The HCA Healthcare Awards of Distinction—comprising the Frist Humanitarian Award and the Excellence in Nursing Award—are the highest honors HCA Healthcare bestows...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US0070021086
Adicet Bio Inc
ACET
LISTED
NASDAQ
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
News Preview
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on September 30, 2025.
One individual was hired by Adicet in September 2025 and granted new hire non-qualified stock options...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US29415F1049
Envista Holdings Corp
NVST
LISTED
NYSE
Envista Schedules Third Quarter 2025 Earnings Call
News Preview
BREA, Calif., Sept. 30, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2025 on Thursday, October 30, 2025. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one h...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US46266C1053
IQVIA Holdings Inc
IQV
LISTED
NYSE
IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025
News Preview
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its third-quarter 2025 financial results before the market opens on Tuesday, October 28, 2025. The IQVIA management team will also host a co...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US98978V1035
Zoetis Inc
ZTS
LISTED
NYSE
Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle
News Preview
Zoetis Inc. today announced that Dectomax®-CA1 Injectable is the first and only parasite control product to receive conditional approval from the U.S. Food and Drug Administration for the prevention and treatment of infestations caused by the larvae of Cochliomyia hominivorax (myiasis), and prevention of reinfestation for 21 days. This conditional...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
30.09.2025
ISIN: US29251M1062
Enanta Pharmaceuticals Inc
ENTA
LISTED
NASDAQ
Enanta Pharmaceuticals Announces Proposed Public Offering of Common Stock
News Preview
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced it has commenced an underwritten public offering for $50.0 million of shares of its common stock. All of the shares are being offered by Enanta. In addition, Enanta i...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
AbbVie Begins Construction on $70 Million Expansion to Further Increase Biologics Manufacturing and R&D Presence in the U.S.
News Preview
Expansion increases biologics manufacturing for immunology and oncology medicines
Milestone marks progress on
AbbVie's long-term commitment to U.S. manufacturing...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US7473241013
Pyxis Oncology Inc
PYXS
LISTED
NASDAQ
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
BOSTON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation antibody-drug conjugate (‘ADC’) therapeutics for difficult-to-treat cancers, reported today that Pyxis Oncology’s Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 382...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US76129W1053
Retractable Technologies, Inc.
RVP
LISTED
XASE
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
News Preview
Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends c...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US47973J1025
Joint Corp
JYNT
LISTED
NASDAQ
The Joint Corp. Names Debbie L. Gonzalez Chief Marketing Officer
News Preview
- CMO with extensive experience in brand building, franchising and strategic growth – - CMO with extensive experience in brand building, franchising and strategic growth –...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US03168L1052
Amneal Pharmaceuticals Inc
AMRX
LISTED
NASDAQ
Amneal to Report Third Quarter 2025 Results on October 30, 2025
News Preview
BRIDGEWATER, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), a global biopharmaceutical company, today announced that the Company will release its third quarter 2025 financial results on Thursday, October 30, 2025, prior to market open. The Company will host an audio webcast at 8:3...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US90400D1081
Ultragenyx Pharmaceutical Inc
RARE
LISTED
NASDAQ
Ultragenyx Appoints Eric Olson as Chief Business Officer and Executive Vice President
News Preview
NOVATO, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced the appointment of Eric Olson as chief business officer (CBO) and executive vice president effective September 22, 2025, following the planned retirement of Thomas Kassberg. Mr. Olson will be responsible for leading the company’s busi...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US75886F1075
Regeneron Pharmaceuticals Inc
REGN
LISTED
NASDAQ
Regeneron to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on October 28, 2025
News Preview
TARRYTOWN, N.Y., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its third quarter 2025 financial and operating results on Tuesday, October 28, 2025, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
Newsweek, Statista name Encompass Health "America's Most Awarded Leader in Inpatient Rehabilitation" for sixth consecutive year
News Preview
BIRMINGHAM, Ala., Sept. 30, 2025 /PRNewswire/ -- Encompass Health today announced it has been named "America's Most Awarded Leader in Inpatient Rehabilitation" by Newsweek and Statista for the sixth consecutive year. Newsweek and Statista recently released the 2025 America's Best Physical Rehabilitation Centers l...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US7170811035
Pfizer Inc
PFE
LISTED
NYSE
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients
News Preview
Pfizer Inc. (NYSE: PFE) today announced a historic agreement with the Trump Administration that will ensure U.S. patients pay lower prices for their prescription medicines while strengthening America’s role as the global leader in biopharmaceutical innovation.
In response to the four points covered in the President’s July 31st letter, Pfizer has...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX INVESTIGATION ALERT: MoonLake Immunotherapeutics Trial Results Triggers Securities Fraud Investigation after Stock Plummets 90% -- Investors Urged to Contact BFA Law
News Preview
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into MoonLake Immunotherapeutics (NASDAQ: MLTX) for potential violations of the federal securities laws.
If you invested in MoonLake, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/moonlake-immunotherapeutics.
Wh...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Sept. 30, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX).
IF YOU ARE AN...
Themefolio
Profiler
Peergroup
© ActuNews
30.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion Publishes First Half 2025 Results
News Preview
Leuven, BELGIUM – September 30, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, published today its financial and business update for the six-month period ending June 30, 2025.
The half-year report is available in the ‘Investors' section of the Company's webs...
Themefolio
Profiler
Peergroup
© ActuNews
30.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion publie ses résultats du premier semestre 2025
News Preview
Louvain, BELGIQUE – 30 Septembre, 2025 – 18:00 CET - Oxurion NV (Euronext Brussels: OXUR), entreprise biopharmaceutique basée à Louvain, a publié aujourd'hui ses résultats financiers et opérationnels pour le semestre clos le 30 Juin 2025.
Le rapport semestriel est disponible dans la section ‘...
Themefolio
Profiler
Peergroup
© ActuNews
30.09.2025
ISIN: BE0974487192
Oxurion NV
OXUR
LISTED
EURONEXT
Oxurion maakt halfjaarresultaten 2025 bekend
News Preview
Leuven, BELGIË – 30 September 2025 – 18:00 CET Oxurion NV (Euronext Brussel: OXUR) (de Vennootschap), een biofarmaceutisch bedrijf met hoofdkantoor in Leuven, maakt vandaag haar financiële en zakelijke update bekend voor het half jaar dat eindigde op 30 juni 2025.
Het halfjaarverslag is beschikbaar in de rubriek ‘Investe...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
Full renewal of the Board of Directors Election of Dr. Markus Cappel as Chairman of the Board of Directors
News Preview
Full renewal of the Board of DirectorsElection of Dr. Markus Cappel as Chairman of the Board of Directors...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
Altimmune, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ALT
News Preview
The DJS Law Group reminds investors of a class action lawsuit against Altimmune, Inc. (“Altimmune” or “the Company”) (NASDAQ: ALT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Shareholders who purchased shares of ALT during the cla...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: FR0010557264
AB Science SA
AB
LISTED
EURONEXT
AB Science announces a slight delay in the publication of its 2025 half-year financial report
News Preview
PRESS RELEASE...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: FR0010259150
Ipsen SA
IPN
LISTED
EURONEXT
IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2025
News Preview
Attachment...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
BetterInvesting™ Magazine Update on Vertiv Holdings Co. (NYSE: VRT) and CVS Health Corp. (NYSE: CVS)
News Preview
TROY, Mich., Sept. 30, 2025 /PRNewswire/ -- Vertiv Holdings Co.'s recent report has investors wondering if the company's stock is fairly valued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine consider Vertiv Holdings Co. (NYSE: VRT) as worthy...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: US4618741098
eXoZymes Inc
EXOZ
LISTED
NASDAQ
Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees
News Preview
LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 30, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced that two of its senior leaders - CCO Damien Perriman and VP of Development,...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: FR0012882389
Equasens
EQS
LISTED
EURONEXT
EQUASENS : Mise à disposition du rapport financier semestriel 2025
News Preview
Villers-lès-Nancy, le 30 septembre 2025 - 18h00 (CET)...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: FR0014008VX5
Euroapi S.A.
EAPI
LISTED
EURONEXT
Change in Board’s Composition
News Preview
Paris – September 30, 2025 - EUROAPI today announces that, in line with best governance’s practices, and following his appointment as Recipharm’s Chief Financial Officer, effective October 1st, 2025, Rodolfo J. Savitzky will step down from his role as EUROAPI’s Independent Director and Chair of the Audit Committee, effective December 31, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30
News Preview
SALT LAKE CITY, Sept. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be participating in a webcast presentation and hosting one...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US14149Y1082
Cardinal Health Inc
CAH
LISTED
NYSE
Cardinal Health to expand pharmaceutical distribution network with new Indianapolis facility
News Preview
DUBLIN, Ohio, Sept. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced plans for a new flagship forward distribution center in Indianapolis, Indiana that will further expand and modernize its national pharmaceutical distribution network. The state-of-the-art forward distribution center will feat...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Total number of shares and voting rights in Zealand Pharma as of September 30, 2025
News Preview
Company announcement – No. 21 / 2025...
Themefolio
Profiler
Peergroup
© Newsfile
30.09.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group Closes Earn-Out Agreement of Via Cibo Restaurant Chain
News Preview
Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is pleased to announce the closing of the earn-out agreement regarding the acquisition of the Via Cibo Restaurant Chain ("Via Cibo"). Via Cibo deliv...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US6700021040
Novavax Inc
NVAX
LISTED
NASDAQ
Novavax Announces Progress on Sanofi Agreement
News Preview
GAITHERSBURG, Md., Sept. 30, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced progress on its collaboration and license agreement (CLA) with Sanofi regarding Novavax's Matrix-M® adjuvant. The companies have amended their CLA to expand Sanofi's license to include use of Novavax's Matrix-M adjuvant...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US1266501006
CVS Health Corp
CVS
LISTED
NYSE
CVS Health to hold third quarter 2025 earnings conference call
News Preview
WOONSOCKET, R.I., Sept. 30, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, October 29th, 2025, at 8:00 a.m. ET to discuss third quarter 2025 financial results....
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US88033G4073
Tenet Healthcare Corp
THC
LISTED
NYSE
Tenet to Report Its Third Quarter 2025 Results on October 28th
News Preview
Tenet Healthcare Corporation (NYSE: THC) will release its third quarter 2025 results before the market opens on Tuesday, October 28, 2025, to be followed by a conference call at 9:30 a.m. CT (10:30 a.m. Eastern Time).
A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet’s website at www.ten...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR
News Preview
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the manufacturer of the Implantable Collamer® Lens (ICL), today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR), in connection with...
Themefolio
Profiler
Peergroup
© Newsfile
30.09.2025
ISIN: CA75671E1097
Red Light Holland Corp.
TRIP
LISTED
CSE
Red Light Holland Receives Official Psilocybin COA Through FDA-Compliant, DEA-Registered Partner, Irvine Labs, USA
News Preview
Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truff...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US52635N1037
LENZ Therapeutics Inc
LENZ
LISTED
NASDAQ
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
News Preview
VIZZ sample distribution initiated nationwide to Eye Care Professionals
Commercial product shipments to be initiated in October to consumers with broad product availability by mid-Q4 2025
VIZZ is the first and...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US04351N1063
Ascend Wellness Holdings, Inc
AAWH.U
LISTED
CSE
AWH Closes $9.3 Million Mortgage Financing on Three Ohio Properties
News Preview
NEW YORK, Sept. 30, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH" or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a leading multi-state, vertically integrated cannabis operator, entered into and closed, effective September 12, 2025, a $9,345,000 secured financing transaction with CF Bank, pursuant to w...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US00846U1016
Agilent Technologies Inc
A
LISTED
NYSE
Agilent Announces New Insight Series Alarm Resolution Systems for Airport Security Screening
News Preview
Agilent Technologies Inc. (NYSE: A) today announced the launch of its new Insight Series Alarm Resolution Systems, designed to enhance safety and streamline operations at airport security checkpoints worldwide. The Insight Series includes the Insight300M and InsightBLS, advanced liquid explosive detection systems (LEDs) that meet global regulation...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Natera Announces Publication of Signatera™ Validation Study in Testicular Cancer
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of a peer-reviewed manuscript in the Journal of Clinical Oncology - Precision Oncology (JCO PO). The paper features results from a multi-institutional study evaluating circulating tumor DNA (ctDNA) as a prognostic biomarker for pat...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the appointment of Lisa Gurry as Chief Business Officer (CBO), effective immediately. In this newly-created role, Gurry will lead GeneDx’s next phase of transformation, advancing data and information services across biopharma, health sys...
Themefolio
Profiler
Peergroup
© Newsfile
30.09.2025
ISIN: US68764Y2072
OS Therapies, Inc
OSTX
LISTED
XASE
OS Therapies Provides OST-HER2 UK MHRA and US FDA Osteosarcoma Regulatory Update
News Preview
Company updates sequence of OST-HER2 regulatory submissions, prioritizing UK MHRA conditional Marketing Authorisation Application (MAA) submission following positive August 2025 Scientific Advice Meeting feedback from UK MHRAIn principle, UK MHRA accepts use of historical control arm to support conditional MAAUK MHRA conditional MAA and US FDA Biol...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US0043971052
Accuray Inc
ARAY
LISTED
NASDAQ
Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care
News Preview
MADISON, Wis., Sept. 30, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced today the signing of a memorandum of understanding (MOU) to advance online adaptive radiotherapy (OART) on the Accuray helical radiation treatm...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US67080N1019
Nuvation Bio Inc
NUVB
LISTED
NYSE
Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI™ (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer
News Preview
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced it has enrolled the first patient in TRUST-IV (NCT07154706), a Phase 3 study evaluating the efficacy and safety of IBTROZI™ (taletrectinib), a next-generation ROS1 inhibitor, versus placebo for the adju...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US5049221055
Labcorp Holdings Inc
LH
LISTED
NYSE
Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities
News Preview
Labcorp to leverage Roche's digital pathology technology to expand access, enhance efficiency and support AI integration across anatomic pathology services
BURLINGTON, N.C., Sept. 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and com...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: CH1384053976
NLS Pharmaceutics AG
NLSP
LISTED
NASDAQ
NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting
News Preview
Vote clears final corporate milestone, paving the way for the closing of the merger and the combined company of NewCelX Ltd., a Nasdaq-listed biotechnology company
ZURICH, Sept. 30, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: DK0060448595
Coloplast A/S
COLO B
LISTED
CPH
Coloplast A/S - Financial Calendar 2025-26
News Preview
Please see enclosed pdf....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US2546041011
Disc Medicine Inc
IRON
LISTED
NASDAQ
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)
News Preview
WATERTOWN, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the submission of a New Drug Application (NDA) to the U.S. Foo...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: JP3546800008
Terumo Corporation
45430
LISTED
XJPX
Kenya, Uganda and Côte d'Ivoire Partner with Terumo Blood and Cell Technologies to Build Coordinated National Care Frameworks for Sickle Cell Care
News Preview
LAKEWOOD, Colo., Sept. 30, 2025 /PRNewswire/ -- In a landmark move, the Ministries of Health of Kenya and Côte d'Ivoire, together with Uganda's Joint Clinical Research Centre (JCRC) under the stewardship of the Uganda Ministry of Health, have signed three Memoranda of Understanding (MoUs) with Terumo Blood and Ce...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk
News Preview
Ozempic® is now available at this reduced price to eligible self-pay LifeMD patients Ozempic® is now available at this reduced price to eligible self-pay LifeMD patients...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US52635N1037
LENZ Therapeutics Inc
LENZ
LISTED
NASDAQ
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
News Preview
VIZZ sample distribution initiated nationwide to Eye Care Professionals...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US7743743004
Rockwell Medical Inc
RMTI
LISTED
NASDAQ
Rockwell Medical Promotes Heather Hunter to Chief Operating Officer
News Preview
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Heather Hunter was promoted to Chief Operating Officer, and will continue to report to the Company's President and CEO, D...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
